American Renal Associates Holdings, Inc (ARA) News
Filter ARA News Items
ARA News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Latest ARA News From Around the Web
Below are the latest news stories about American Renal Associates Holdings Inc that investors may wish to consider to help them evaluate ARA as an investment opportunity.
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Following Mergers – WTRE, ARA, RESI, NKNEW YORK, Dec. 30, 2020 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Watford Holdings Ltd. (NASDAQ: WTRE) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Arch Capital Group Ltd. for $35.00 per share. If you are a Watford shareholder, click here to learn more about your rights and options.American Renal Associates Holdings, Inc. (NYSE: ARA) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Innovative Renal Care, LLC, an affiliate of Nautic Partners, LLC, for $11.50 per share in cash. If you are an American Renal shareholder, click here to learn more about your... |
Moore Kuehn Encourages CBMG, CLCT, TNAV, and ARA Investors to Contact Law FirmNEW YORK, Dec. 29, 2020 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a securities litigation law firm located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair to shareholders. Moore Kuehn may ultimately seek increased consideration, additional disclosures, or other relief and benefits on behalf of the shareholders of these companies: * Cellular Biomedicine Group, Inc. (NASDAQ: CBMG) A proxy was recently filed with the SEC regarding the acquisition of Cellular Biomedicine by a consortium led by the company’s CEO Bizuo Liu. Under the proposed transaction, shareholders of Cellular Biomedicine will receive $19.75 for every share owned. The investigation concerns whether Cellular Biomedicine’s board of di... |
SHAREHOLDER ALERT: Halper Sadeh LLP Investigates the Following Companies - PRGX, STND, NK, EIDX, ARAHalper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: |
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Following Companies - STND, EIDX, WTRE, ARA, CGIXHalper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: |
Lifshitz Law Firm, P.C. Announces Investigation of ARA, BBIO, EIDX, CIT, EMIS, FCNCA, FCNCB, EV, MS, NAV, STND, and WTREAmerican Renal Associates Holdings, Inc. (NYSE: ARA) |
ALERT: Halper Sadeh LLP Encourages IPHI, EIGI, ARA, and AKER Shareholders to Contact the FirmHalper Sadeh LLP, a global investor rights law firm, announces it is investigating the following mergers: |
Lifshitz Law Firm, P.C. Announces Investigation of ARA, BLDR, CIT, and EVNEW YORK, NY / ACCESSWIRE / December 3, 2020 / American Renal Associates Holdings, Inc. |
Here is What Hedge Funds Think About American Renal Associates Holdings, Inc (ARA)In this article we will analyze whether American Renal Associates Holdings, Inc (NYSE:ARA) is a good investment right now by following the lead of some of the best investors in the world and piggybacking their ideas. There’s no better way to get these firms’ immense resources and analytical capabilities working for us than to follow […] |
Halper Sadeh LLP Reminds Shareholders About Its Ongoing Merger Investigations; Investors are Encouraged to Contact the Firm – ARA, PNM, IPHI, EIGINEW YORK, Dec. 01, 2020 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating: American Renal Associates Holdings, Inc. (NYSE: ARA) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Innovative Renal Care, LLC, an affiliate of Nautic Partners, LLC, for $11.50 per share in cash. If you are an American Renal shareholder, click here to learn more about your rights and options.PNM Resources, Inc. (NYSE: PNM) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Avangrid, Inc. for $50.30 in cash per share. If you are a PNM Resources shareholder, click here to learn more about your rights and options.Inph... |
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of IPHI, ARA, PNM, and EIGI BuyoutsWILMINGTON, Del. , Dec. 01, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating:Inphi Corporation (NASDAQ GS: IPHI) regarding possible breaches of fiduciary duties and other violations of law related to Inphi’s agreement to be acquired by Marvell Technology Group Ltd. Under the terms of the agreement Inphi’s shareholders will receive 2.323 shares of Marvell Technology’s common stock and $66.00 in cash per share. To learn more about this investigation and your rights, visit: https://www.rigrodskylong.com/cases-inphi-corporation.American Renal Associates Holdings, Inc. (NYSE: ARA) regarding possible breaches of fiduciary duties and other violations of law related to American Renal Associates’ agreement to be acquired by affiliates of Nautic Partners, LLC. Un... |